trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from
) commercial banks; (2) finance companies; (3) securities companies; (4) credit foncier companies; (5) insurance companies; (6) juristic persons but not include any juristic person as prescribed in (8); (7
) commercial banks; (2) finance companies; (3) securities companies; (4) credit foncier companies; (Translation) -2- (5) insurance companies; (6) juristic persons but not include any juristic person as
in the category of securities trading under the foreign law; “Institutional client” means the following customers: (1) commercial banks; (2) finance companies; (3) securities companies; (4) credit
higher distribution costs and finance costs. Operating Results Analysis of for the consolidated financial statements for the six-month period ended 30 June 2019 The table below presents the Company’s total
% 1,177,449 19% 1,509,798 21% 1,461,173 23% Current portion of long-term loans from financial institutio 100,800 2% - 0% 120,000 2% 132,000 2% Current portion of finance lease liabilities 2,968 0% 1,561 0
administrative expenses by Baht 85 million. 3. Finance Costs, for the Third quarter and 9-month period of 2017, which consist of interest expense, bank charges and financial advisory fees increased by Baht 13
Limited (the “Company”) Board of Meeting No.1/2018 on 26 February 2018, the resolution to certify the Company’s financial statements and performance for the yearly ending 31 December 2017 which has already
., Ltd. such as fees for financial and legal advisory and the transfer transaction had been already completed on 20 July, 2018. Finance Cost The finance cost of the company and subsidiaries was Baht 2.60
reviewed the 2 nd quarter financial statements as of August 31, 2018 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview